ANNUAL REPORT

FOR THE ⁜YEAR TO 31 MARCH 2022

CONTENTS

STRATEGIC REPORT

CHAIRMAN'S STATEMENT

05

GROUP MANAGING DIRECTOR'S REPORT

07

STRATEGY

10

DIRECTORS

11

SECTION 172(1) STATEMENT

15

OPERATING AND FINANCIAL REVIEW

18

PRINCIPAL RISKS AND UNCERTAINTIES

19

GOVERNANCE

CORPORATE GOVERNANCE STATEMENT

24

AUDIT COMMITTEE REPORT

29

REPORT OF THE REMUNERATION COMMITTEE

31

CONSOLIDATED FINANCIAL STATEMENTS

REPORT OF THE DIRECTORS

34

DIRECTORS' RESPONSIBILITIES STATEMENT

36

INDEPENDENT AUDITOR'S REPORT

37

CONSOLIDATED INCOME STATEMENT

46

CONSOLIDATED BALANCE SHEET

47

CONSOLIDATED CASH FLOW STATEMENT

48

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY

49

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

50

PARENT COMPANY FINANCIAL STATEMENTS

PARENT COMPANY BALANCE SHEET

70

PARENT COMPANY STATEMENT OF CHANGES IN EQUITY

71

NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS

72

LETTER TO SHAREHOLDERS

78

NOTICE OF THE ANNUAL GENERAL MEETING

81

Annual Report & Accounts 2022

1

BOARD OF DIRECTORS AND ADVISORS

DIRECTORS

W Brown - Executive Chairman

C Stretton - Group Managing Director

I Anthony - Director of Clinical and Regulatory Affairs L Smith - Chief Financial Officer

J McKenna - Director of Marketing I Ardill - Non-Executive Director G Berg - Non-Executive Director J Ely - Non-Executive Director

COMPANY SECRETARY

K M Full FCCA

REGISTERED OFFICE

c/o Davidson Chalmers Stewart LLP 163 Bath Street

Glasgow

G2 4SQ

LAWYERS

Davidson Chalmers Stewart LLP

163 Bath Street

Glasgow

G2 4SQ

Burness Paull LLP

50 Lothian Road

Festival Square

Edinburgh

EH3 9WJ

INDEPENDENT AUDITOR

Grant Thornton UK LLP

Statutory Auditor

Chartered Accountants

101 Cambridge Science Park

Milton Road

Cambridge

CB4 0FY

HEAD OFFICE

NOMINATED ADVISER AND STOCKBROKERS

2 Drummond Crescent

Cenkos Securities plc

Irvine

6,7,8 Tokenhouse Yard

Ayrshire

London

KA11 5AN

EC2R 7AS

web: www.rualifesciences.com

email: info@rualifesciences.com

REGISTRARS

Equiniti Limited

Aspect House

Spencer Road

Lancing

West Sussex

BN99 6DA

Registered in Scotland, Company No.SC170071

Financial statements will be circulated to Shareholders and copies of the announcement will be made available from the Company's registered office. Dealings permitted on Alternative Investment Market (AIM) of the London Stock Exchange.

2 RUA Life Sciences plc

STRATEGIC REPORT

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Rua Life Sciences plc published this content on 15 July 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 July 2022 12:03:07 UTC.